Clinical Trial

The GErman Italian Spanish Takotsubo (GEIST) Registry

Study acronym: GEIST
Recruiting
View on ClinicalTrials.gov →
Summary
GEIST is a multicenter, international observational registry of patients with Takotsubo syndrome. Data regarding the clinical profile (demographic characteristics, clinical presentation, laboratory measures, electrocardiography /echocardiography / coronary angiography parameters, treatment and medication), in-hospital course and complications and short-/long-term outcome are collected prospectively and retrospectively to increase the understanding of the disease.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-04-22; most recent amendment 2025-12-18.
Trial Details
NCT Number NCT04361994
Lead Sponsor Prof. Dr. med. Ingo Eitel
Collaborators: University of Foggia
Conditions Takotsubo Syndrome
Enrollment 500 participants
Start Date 2015-04
Primary Completion 2035-12 (estimated)
Study Completion 2035-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-26